Female Urology

Latest News

Data show short-term benefit of certain hormonal treatments for GSM
Data show short-term benefit of certain hormonal treatments for GSM

September 10th 2024

Data showed that vaginal estrogen, vaginal DHEA, oral ospemifene, and vaginal moisturizers may provide benefit in the management of symptoms related to GSM.

Collaboration to advance market launch of ProVate device for pelvic organ prolapse
Collaboration to advance market launch of ProVate device for pelvic organ prolapse

September 6th 2024

Topical sildenafil cream found safe, tolerable in female sexual arousal disorder
Topical sildenafil cream found safe, tolerable in female sexual arousal disorder

August 27th 2024

FDA approves cefepime/enmetazobactam for complicated UTI
FDA approves cefepime/enmetazobactam for complicated UTI

February 27th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.